SCHEDULE 13G/A 0001306923 XXXXXXXX LIVE 4 Common Stock 09/30/2024 0001479290 Revance Therapeutics, Inc. 761330109 1222 Demonbreun Street 20th Floor Nashville TN 37203 Rule 13d-1(b) Patrick Lee, MD b X1 0.00 1611787.00 0.00 1611787.00 1611787.00 N 1.54 HC IN Anthony Joonkyoo Yun, MD b X1 0.00 1611787.00 0.00 1611787.00 1611787.00 N 1.54 HC IN Palo Alto Investors LP b CA 0.00 1611787.00 0.00 1611787.00 1611787.00 N 1.54 IA PN PAI LLC b CA 0.00 1611787.00 0.00 1611787.00 1611787.00 N 1.54 IA OO Revance Therapeutics, Inc. 1222 Demonbreun Street, 20th Floor, Nashville, TN, 37203 Palo Alto Investors LP ("PAI") PAI LLC ("PAI GP") Patrick Lee, MD Anthony Joonkyoo Yun, MD (collectively, the "Filers"). The address of the principal place of the Filers is located at: 470 University Avenue, Palo Alto, CA 94301 For citizenship of Filers, see Item 4 of the cover sheet for each Filer. N IA HC See Item 9 of the cover page for each Filer. See Item 11 of the cover page for each Filer for See Item 5 of the cover page for each Filer. See Item 6 of the cover page for each Filer. See Item 7 of the cover page for each Filer. See Item 8 of the cover page for each Filer. N Y N PAI is a registered investment adviser and investment adviser of investment limited partnerships, and is the investment adviser to other investment funds. PAI GP is the general partner of investment limited partnerships. PAI's clients have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Stock. Y N Dr. Lee and Dr. Yun co-manage PAI. The Filers are filing this Schedule 13G jointly, but not as members of a group, and each of them expressly disclaims membership in a group. Each Filer disclaims beneficial ownership of the Stock except to the extent of that Filer's pecuniary interest therein. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. EXHIBIT A GREEMENT FOR JOINT FILING OF SCHEDULE 13G Patrick Lee, MD Patrick Lee, MD 01/10/2025 Anthony Joonkyoo Yun, MD Anthony Joonkyoo Yun, MD 01/10/2025 Palo Alto Investors LP Angela Nguyen-Dinh 01/10/2025 PAI LLC Patrick Lee, MD 01/10/2025